Financing Cash Flow
Thermo Fisher Scientific Financing Cash Flow increased by 657.9% to $3.53B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 196.2%, from -$3.67B to $3.53B. Over 3 years (FY 2021 to FY 2025), Financing Cash Flow shows a downward trend with a -35.1% CAGR.
Analysis
How to read this metric
A large negative value typically indicates a company is returning capital to shareholders or paying down debt, while a positive value suggests the company is raising external capital to fund operations or acquisitions.
Detailed definition
This metric represents the net flow of cash between a company and its capital providers, including shareholders and lend...
Peer comparison
Large-cap peers like Microsoft or Alphabet similarly show large negative financing outflows due to aggressive share repurchase programs and dividend distributions.
cf_net_cash_from_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$76.00M | $3.04B | $8.47B | -$3.15B | -$1.91B | -$151.00M | -$2.59B | -$1.46B | $1.86B | -$1.43B | -$1.82B | -$115.00M | -$1.19B | -$3.67B | -$102.00M | -$991.00M | -$632.00M | $3.53B |
| QoQ Change | — | >999% | +178.5% | -137.1% | +39.4% | +92.1% | <-999% | +43.8% | +227.4% | -177.0% | -27.5% | +93.7% | -934.8% | -208.1% | +97.2% | -871.6% | +36.2% | +657.9% |
| YoY Change | — | — | — | — | <-999% | -105.0% | +17.6% | +23.6% | >999% | — | +29.8% | +92.1% | -164.2% | -156.7% | +94.4% | -761.7% | +46.9% | +196.2% |
Financing Cash Flow at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's financing cash flow?
- Thermo Fisher Scientific (TMO) reported financing cash flow of $3.53B in Q4 2025.
- How has Thermo Fisher Scientific's financing cash flow changed year-over-year?
- Thermo Fisher Scientific's financing cash flow increased by 196.2% year-over-year, from -$3.67B to $3.53B.
- What is the long-term trend for Thermo Fisher Scientific's financing cash flow?
- Over 3 years (2021 to 2025), Thermo Fisher Scientific's financing cash flow has grown at a -35.1% compound annual growth rate (CAGR), from $6.58B to $1.80B.
- What does financing cash flow mean?
- The total amount of money a company spends or receives from borrowing debt and managing its own shares and dividends.